Literature DB >> 27141429

Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation.

Efraín A Cermeño1, Andrés J García1.   

Abstract

The discovery and subsequent isolation of tumor-initiating cells (TICs), a small population of highly tumorigenic and drug-resistant cancer cells also called cancer stem cells (CSCs), have revolutionized our understanding of cancer. TICs are isolated using various methodologies, including selection of surface marker expression, ALDH activity, suspension culture, and chemotherapy/drug resistance. These methods have several drawbacks, including their variability, lack of robustness and scalability, and low specificity. Alternative methods of purification take advantage of biophysical properties of TICs including their adhesion and stiffness. This review will provide a brief overview of TIC biology as well as review the most important methods of TIC isolation with a focus on biophysical methods of TIC purification.

Entities:  

Keywords:  Cancer stem cells; Tumor-initiating cells; adhesion; isolation and purification; stemness; tumorigenicity

Year:  2016        PMID: 27141429      PMCID: PMC4851112          DOI: 10.1007/s40778-016-0036-6

Source DB:  PubMed          Journal:  Curr Stem Cell Rep


  180 in total

1.  Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.

Authors:  V Samanna; H Wei; D Ego-Osuala; M A Chellaiah
Journal:  Exp Cell Res       Date:  2006-04-24       Impact factor: 3.905

2.  Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.

Authors:  Wei-Ming Lin; Uwe Karsten; Steffen Goletz; Ruo-Chuan Cheng; Yi Cao
Journal:  Int J Exp Pathol       Date:  2010-11-11       Impact factor: 1.925

Review 3.  Cancer stem cells: mirage or reality?

Authors:  Piyush B Gupta; Christine L Chaffer; Robert A Weinberg
Journal:  Nat Med       Date:  2009-09-04       Impact factor: 53.440

Review 4.  Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization.

Authors:  Virginia Tirino; Vincenzo Desiderio; Francesca Paino; Alfredo De Rosa; Federica Papaccio; Marcella La Noce; Luigi Laino; Francesco De Francesco; Gianpaolo Papaccio
Journal:  FASEB J       Date:  2012-09-28       Impact factor: 5.191

5.  Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity.

Authors:  R W Storms; A P Trujillo; J B Springer; L Shah; O M Colvin; S M Ludeman; C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

6.  CD13 is a therapeutic target in human liver cancer stem cells.

Authors:  Naotsugu Haraguchi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Masahisa Ohkuma; Ho Min Kim; Hirofumi Akita; Daisuke Takiuchi; Hisanori Hatano; Hiroaki Nagano; Graham F Barnard; Yuichiro Doki; Masaki Mori
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

7.  Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy.

Authors:  Janet M Pavese; Raymond C Bergan
Journal:  Cancer Lett       Date:  2014-07-10       Impact factor: 8.679

8.  Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.

Authors:  Elaine Lai-Han Leung; Ronald R Fiscus; James W Tung; Vicky Pui-Chi Tin; Lik Cheung Cheng; Alan Dart-Loon Sihoe; Louis M Fink; Yupo Ma; Maria Pik Wong
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

9.  Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?

Authors:  J E Noll; S A Williams; L E Purton; A C W Zannettino
Journal:  Blood Cancer J       Date:  2012-09-14       Impact factor: 11.037

10.  Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.

Authors:  Kari R Fischer; Anna Durrans; Sharrell Lee; Jianting Sheng; Fuhai Li; Stephen T C Wong; Hyejin Choi; Tina El Rayes; Seongho Ryu; Juliane Troeger; Robert F Schwabe; Linda T Vahdat; Nasser K Altorki; Vivek Mittal; Dingcheng Gao
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

View more
  2 in total

1.  Cancer Explant Models.

Authors:  Christian T Stackhouse; George Yancey Gillespie; Christopher D Willey
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

2.  Hydrodynamic shear-based purification of cancer cells with enhanced tumorigenic potential.

Authors:  Efraín A Cermeño; Meghan J O'Melia; Woojin M Han; Austin Veith; Graham Barber; Emina H Huang; Susan N Thomas; Andrés J García
Journal:  Integr Biol (Camb)       Date:  2020-02-22       Impact factor: 2.192

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.